Significant Ownership of Sofinnova Venture Partners X, L.P.
- Signature - Title
- /s/ Nathalie Auber - Nathalie Auber / Attorney-in-Fact
- Location
- Menlo Park, CA
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by Sofinnova Venture Partners X, L.P..
Follow Filing Activity
Follow Sofinnova Venture Partners X, L.P. and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
Useful next steps after a schedule filing
Use the page below that answers the next obvious question about this reporting manager or security.
- Latest 13D/G reports to compare this manager with other current ownership disclosures.
- Latest insider ownership reports if you want insider activity alongside the beneficial ownership record.
- Latest 13F portfolio filings for broader institutional context.
- Latest investment quarter holder pages when the next step is security-level holder history.
Significant Ownership of Sofinnova Venture Partners X, L.P.
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| VERA | Vera Therapeutics, Inc. | Class A Common Stock, $0.001 par value | 4% | $128,465,927 | 2,847,837 | Dr. Maha Katabi ("Katabi") | 10 Dec 2025 | ||
| JBIO | Jade Biosciences, Inc. | Common Stock, par value $0.0001 per share | 0.3% | $1,617,308 | 107,391 | Sofinnova Venture Partners X, L.P. ("SVP X") | 28 Apr 2025 |
Schedules 13D/G Reported by Sofinnova Venture Partners X, L.P.:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.